Cancer‐ and Chemotherapy‐Induced Musculoskeletal Degradation
ABSTRACT Mobility in advanced cancer patients is a major health care concern and is often lost in advanced metastatic cancers. Erosion of mobility is a major component in determining quality of life but also starts a process of loss of muscle and bone mass that further devastates patients. In additi...
Main Authors: | Kathleen M Sturgeon, Katlynn M Mathis, Connie J Rogers, Kathryn H Schmitz, David L Waning |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-03-01
|
Series: | JBMR Plus |
Subjects: | |
Online Access: | https://doi.org/10.1002/jbm4.10187 |
Similar Items
-
Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice
by: Alyson L. Essex, et al.
Published: (2019-11-01) -
Chemotherapy in the management of periosteal osteosarcoma: A narrative review
by: Tarek Assi, et al.
Published: (2021-10-01) -
What’s new in musculoskeletal oncology
by: Costantino Errani, et al.
Published: (2021-08-01) -
Effects of Resveratrol Supplementation on Methotrexate Chemotherapy‐Induced Bone Loss
by: Alice M. C. Lee, et al.
Published: (2017-03-01) -
Burden of Disease in Patients With Tumor‐Induced Osteomalacia
by: Fernando Jerkovich, et al.
Published: (2021-02-01)